Role of mucosal immunity in herpes simplex virus infection

Journal of Immunology

Volumn 160, Issue 12, 1998, Pages 5998-6003

  Kuklin, Nelly A ^a   Daheshia, Massoud ^a   Chun, Sangjun ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; FEMALE; HERPES SIMPLEX; HOST RESISTANCE; INFECTION RESISTANCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; T LYMPHOCYTE ACTIVATION; VAGINA MUCOSA; VIRUS INDUCTION; VIRUS INHIBITION;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HERPES SIMPLEX; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; VACCINIA VIRUS; VAGINITIS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0032526588     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Corey, L., and P. G. Spear. 1985. Infections with herpes simplex viruses. Parts 1 and 2. N. Engl. J. Med. 314:686, 749.
2. Stanberry, L. R. 1996. Herpes immunization on the threshold. J. Eur. Acad. Dermatol. Venereal. 7:120.
3. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membranes exon of the immunoglobulin μ chain gene. Nature 350:423.
4. Koller, B. H., and O. Smithies. 1989. Inactivating the beta-2 microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86:8932.
5. Killeen, N., S. Sawada, and D. R. Littman. 1993. Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J. 12:1547.
6. Kuklin, N., M. Daheshia, K. Karem, E. Manickan, and B. T. Rouse. 1997. Induction of mucosal immunity against herpes simplex virus by plasmid DNA Immunization. J. Virol. 71:3138.
7. Cremer, K. J., M. Mackett, C. Wohlenberg, A. L. Notkins, and B. Moss. 1985. Vaccinia virus recombinant expressing HSV-1 type 1 glycoprotein D prevents latent herpes in mice. Science 288:737.
8. Ling, X. M., M. A. Ali, H. Openshaw, and E. M. Cantin. 1996. Deletion of the carboxy-terminus of herpes simplex virus the 1 (HSV-1) glycoprotein B does not affect ohgomerisation, heparin-binding activity, or its ability to protect against HSV challenge. Arch. Virol. 141:1153.
9. Parr, M. B., L. Kepple, M. R. McDermott, M. D. Drew, J. J. Bonzzola, and E. L. Parr. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex type 2. Lab. Invest. 70:369.
10. Overall, J. C., E. R. Kern, R. L. Schlitzer, S. B. Friedman, and L. A. Glasgow. 1975. Genital herpes virus infection in mice. I. Development of an experimental model. infect. Immun. 11:476.
11. Gallichan, W. S., D. C. Johnson, F. L. Graham, and K. L. Rosenthal. 1993. Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B. J. Infect. Dis. 168:622.
12. Gallichan, W, S., and K. L. Rosenthal. 1995. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 16:1589.
13. Gallichan, W. S., and K. L. Rosenthal. 1996. Effects of estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2-infection in the genital tract. Virology 224:487.
14. Palladino, G., K. Mozdzanowska, G. Washko, and W. Gerhard. 1995. Virus-neutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J. Virol. 64:2075.
15. Liang S., K. Mozdzanowsha, G. Palladino, and W. Gerhard. 1994. Heterosubtypic immunity of influenza type A virus in mice: effector mechanisms and their longevity. J. Immunol. 15:1653.
16. Deck, R. R., C. M. DeWitt, J. J. Donnelly, M. A. Liu, and J. Burner. 1997. Characterization of humoral immune responses induced by influenza hemagglutinin DNA vaccine. Vaccine 15:71.
17. Doherty, P. C., W. Allan, and M. Eichilberger. 1992. Roles of antibodies and T cells subsets in viral immunity. Annu. Rev. Immunol. 10:123.
18. Eis-Hubinger A. M., D. S. Schmidt, and K. E. Schneweis. 1993. Ann glycoprotein B-monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes. J. Gen. Virol. 74:379.
19. Whaley, K. J., L. Zeitlin, R. A. Barratt, T. E. Hoen, and R. A. Cone. 1994. Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infection. J. Infect. Dis. 169:647.
20. Sherwood, J. K., L. Zeitlin, K. J. Whaley, R. A. Cone, and M. Saltzman. 1996. Controlled release of antibodies for long term topical passive immunoprotection of female mice against genital herpes. Nat. Biotechnol. 14:468.
21. Pepose, J. S., D. A. Leib, P. M. Smart, and D. L. Easty. 1996. Herpes simplex virus diseases: anterior segment of the eye. In Ocular Infection and Immunity. J. S. Pepose, G. N. Holland, K. R. Wilhelmus, eds. Mosby, St. Louis, p. 905.
22. Brown, Z. A., S. Seleke, J. Zeh, J. Kopelana, A. Maslow, R. L. Ashley, D. H. Watts, S. Berry, R. N. Hern, and L. Corey. 1997. The acquisition of herpes simplex virus during pregnancy. N. Engl. J. Med. 337:509.
23. Prober, C. G., P. A. Hensleigh, F. D. Boucher, L. L. Yasukawa, D. S. Au, and A. M. Arrin. 1988. Use of viral cultures at delivery to identify neonates exposed to herpes simplex virus. N. Engl. J. Med. 318:887.
24. Merriman, H., S. Woods, C. Winter, A. Fahnlander, and L. Corey. 1984. Secretory IgA antibody in servicovaginal secretions from women with genital infection due to herpes simplex virus. J. Infect. Dis. 149:505.
25. Ashley, R. L., L. Corey, J., Dalessio, P. Wilson, M. Remington, G. Barnum, and P. Trethewey. 1994. Protein-specific arrival antibody responses to primary genital herpes simplex virus type 2 infections. J. Infect. Dis. 170: 20.
26. McDermott, M. R., G. H. Goldsmith, K. Rosenthal, and L. J. Brais. 1989. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 159:460.
27. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-γ enhances resolution of herpes simplex virus type 2 infections of the murine genital tract. Virology 229:259.
28. Milligan, G. N., and D. I. Bernstein. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481.
29. Smith, P. M., R. M. Wilcott, R. Chervenale, and S. R. Jennings. 1994. Control of anti cutaneous herpes simplex virus infection: T cell mediated viral clearance is dependant upon interferon-gamma. Virology 202:76.
30. Yu, Z., E. Manickan, and B. T. Rouse. 1996. Role of interferon in immunity to herpes simplex virus. J. Leukocyte Biol. 60:528.
31. Parr, E. L., and M. B. Parr. 1997. Immunoglobulin G is the main protective antibody in mouse vaginal secretions after vaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 71:8109.
32. Martin, S., B. Moss, P. W. Berman, L. A. Lasky, and B. T. Rouse. 1987. The mechanism of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D and cytotoxic T cells. J. Virol. 61:726.
33. Martin, S., E. Cantin and B. T. Rouse. 1989. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus-type 1 glycoproteins. J. Gen. Virol. 70:1359.